Disclosures for "Cord and Brain Stem Extensive Wallerian Degeneration: Rare Sequelae of Pontine Hemorrhage "
-
Dr. Patel has nothing to disclose.
-
Dr. MacLeod has nothing to disclose.
-
Dr. Griffin has nothing to disclose.
-
An immediate family member of Chintan Shah has received personal compensation for serving as an employee of Pfizer, Inc. Chintan Shah has stock in Penumbra, Inc.
-
Emmanuel Obusez has nothing to disclose.
-
Dr. Ruggieri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cleveland Clinic.
-
Dr. Sundararajan has nothing to disclose.
-
Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Horizon.